SUHENDAN EKMEKCIOGLU to Cerebral Hemorrhage
This is a "connection" page, showing publications SUHENDAN EKMEKCIOGLU has written about Cerebral Hemorrhage.
Connection Strength
0.028
-
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors. Cancer. 2014 Jul 15; 120(14):2164-73.
Score: 0.028